Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide

Abstract Background We address the therapeutic relevance of glioblastoma (GBM)’s molecular characterization, focusing on whether a proneural-vs-mesenchymal classification may describe GBM heterogeneity, correlate to stemness and CD44 (a marker often, but conflictingly, used in GBM), and have a progn...

Descripció completa

Dades bibliogràfiques

Autors principals:	Silvia Rancati, Matilde Campolungo, Gerusa Duarte Dalmolin, Pierre Lau, Federica Furia, Alessandro Coppe, Fabio Landuzzi, Manuela Vecchi, Andrea Cavalli, Stefano Gustincich, Nicola Tirelli
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2026-05-01
Col·lecció:	BJC Reports
Accés en línia:	https://doi.org/10.1038/s44276-026-00228-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!